Catalpol suppresses proliferation and facilitates apoptosis of OVCAR-3 ovarian cancer cells through upregulating microRNA-200 and downregulating MMP-2 expression

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 19394-19405

  Gao, Na ^a   Tian, Jian Xin ^a   Shang, Yu Hong ^a   Zhao, Dan Yi ^a   Wu, Tao ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Catalpol; Matrix metalloproteinase 2; MicroRNA 200; Ovarian cancer; OVCAR 3 cell

Indexed keywords

CASPASE 3; CATALPOL; GELATINASE A; MICRORNA 200; IRIDOID; MESSENGER RNA; MICRORNA; MIRN200 MICRORNA, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MTT ASSAY; OVARY CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UPREGULATION; ZYMOGRAPHY; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRIDOID GLUCOSIDES; MATRIX METALLOPROTEINASE 2; MICRORNAS; OVARIAN NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84937538201     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151119394     Document Type: Article

References (24)

1. Jiang, L.; Wang, H.; Li, J.; Fang, X.; Pan, H.; Yuan, X.; Zhang, P. Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transition. Int. J. Mol. Sci. 2014, 15, 11539-11554.
2. Mehtala, J.G.; Torregrosa-Allen, S.; Elzey, B.D.; Jeon, M.; Kim, C.; Wei, A. Synergistic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors. Nanomedicine (Lond.) 2014, in press.
3. Ayyagari, V.N.; Brard, L. Bithionol inhibits ovarian cancer cell growth in vitro—studies on mechanism(s) of action. BMC Cancer 2014, 14, 61.
4. Rafii, A.; Halabi, N.M.; Malek, J.A. High-prevalence and broad spectrum of Cell Adhesion and Extracellular Matrix gene pathway mutations in epithelial ovarian cancer. J. Clin. Bioinforma. 2012, 2, 15.
5. Davies, K.J. The complex interaction of matrix metalloproteinases in the migration of cancer cells through breast tissue stroma. Int. J. Breast Cancer 2014, 2014, 839094.
6. Seo, J.M.; Park, S.; Kim, J.H. Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2. J. Biol. Chem. 2012, 287, 13840-13849.
7. Salido-Guadarrama, I.; Romero-Cordoba, S.; Peralta-Zaragoza, O.; Hidalgo-Miranda, A.; Rodriguez-Dorantes, M. MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. Onco Targets Ther. 2014, 7, 1327-1338.
8. Wen, K.C.; Sung, P.L.; Yen, M.S.; Chuang, C.M.; Liou, W.S.; Wang, P.H. MicroRNAs regulate several functions of normal tissues and malignancies. Taiwan J. Obstet. Gynecol. 2013, 52, 465-469.
9. Koutsaki, M.; Spandidos, D.A.; Zaravinos, A. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett. 2014, 351, 173-181.
10. Kobayashi, M.; Salomon, C.; Tapia, J.; Illanes, S.E.; Mitchell, M.D.; Rice, G.E. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J. Transl. Med. 2014, 12, 4.
11. Zhang, X.; Jin, C.; Li, Y.; Guan, S.; Han, F.; Zhang, S. Catalpol improves cholinergic function and reduces inflammatory cytokines in the senescent mice induced by D-galactose. Food Chem. Toxicol. 2013, 58, 50-55.
12. Fu, K.; Piao, T.; Wang, M.; Zhang, J.; Jiang, J.; Wang, X.; Liu, H. Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice. Int. Immunopharmacol. 2014, 14, S1567-S5769.
13. Liu, Y.R.; Li, P.W.; Suo, J.J.; Sun, Y.; Zhang, B.A.; Lu, H.; Zhu, H.C.; Zhang, G.B. Catalpol provides protective effects against cerebral ischaemia/reperfusion injury in gerbils. J. Pharm. Pharmacol. 2014, 66, 1265-1270.
14. Tian, Y.Y.; An, L.J.; Jiang, L.; Duan, Y.L.; Chen, J.; Jiang, B. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci. 2006, 80, 193-199.
15. Pungitore, C.R.; Leon, L.G.; Garcia, C.; Martin, V.S.; Tonn, C.E.; Padron, J.M. Novel antiproliferative analogs of the Taq DNA polymerase inhibitor catalpol. Bioorg. Med. Chem. Lett. 2007, 17, 1332-1335.
16. Zhu, C.; Ren, C.; Han, J.; Ding, Y.; Du, J.; Dai, N.; Dai, J.; Ma, H.; Hu, Z.; Shen, H.; et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br. J. Cancer 2014, 110, 2291-2299.
17. Ween, M.P.; Oehler, M.K.; Ricciardelli, C. Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(betaig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer. Int. J. Mol. Sci. 2012, 13, 10461-10477.
18. Chekerov, R.; Braicu, I.; Castillo-Tong, D.C.; Richter, R.; Cadron, I.; Mahner, S.; Woelber, L.; Marth, C.; van Gorp, T., et al. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD. Int. J. Gynecol. Cancer 2013, 23, 268-275.
19. Pungitore, C.R.; Ayub, M.J.; Borkowski, E.J.; Tonn, C.E.; Ciuffo, G.M. Inhibition of Taq DNA polymerase by catalpol. Cell Mol. Biol. 2004, 50, 767-772.
20. Martin, O.A.; Garro, H.A.; Kurina Sanz, M.B.; Pungitore, C.R.; Tonn, C.E. In silico study of the inhibition of DNA polymerase by a novel catalpol derivative. J. Mol. Model. 2011, 17, 2717-2723.
21. Grelewski, P.G.; Bar, J.K. The role of p53 protein and MMP-2 tumor/stromal cells expression on progressive growth of ovarian neoplasms. Cancer Investig. 2013, 31, 472-479.
22. Poon, S.L.; Klausen, C.; Hammond, G.L.; Leung, P.C. 37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells. Mol. Endocrinol. 2011, 25, 327-338.
23. Cao, Q.; Lu, K.; Dai, S.; Hu, Y.; Fan, W. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. Int. J. Clin. Exp. Pathol. 2014, 7, 2392-2401.
24. Soubani, O.; Ali, A.S.; Logna, F.; Ali, S.; Philip, P.A.; Sarkar, F.H. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis 2012, 33, 1563-1571.